MHRA Global Access

MHRA GLOBAL ACCESS begins in January 2021 in a new dawn for the sovereign regulator

Australia-Canada-UK-Singapore-Switzerland

The Medicines & Healthcare Products Regulatory Agency has confirmed it will join Australia, Canada, Singapore and Switzerland to form the ‘ACCESS’ consortium from 1st January 2021. The addition of the UK will bring the combined ACCESS population to 145 million people in a new priority medicines market for pharmaceutical companies. The consortium targets provision of high quality safe and effective products across the 5 countries. Submissions in some or all countries will benefit from simultaneous evaluations with reduced evaluation times. Full guidance from the MHRA is scheduled to be published from the 1st January 2021.

For further information visit: gov.uk/government/news/uk-medicines-regulator-joins-up-with-australia-canada-singapore-and-switzerland-regulators